Vanderbilt Institute for Clinical and Translational Research (VICTR)

NIH RePORTER · NIH · UL1 · $10,990,565 · view on reporter.nih.gov ↗

Abstract

Contact PD/PI: Bernard, Gordon R The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional and integrated clinical and translational (C&T) research infrastructure that has raised the quality and scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry, the nation's oldest historically black academic health science institution. VICTR will contribute to the mission of the CTSA program while leveraging unique resources and expertise within VICTR's Hub and elevating the role of health equity in C&T research with these new aims: 1) Leverage VICTR's strong collaborative energy to enhance team science methodologies, integrate community engagement principles for all stages of research, and implement programs designed to support health equity in research; 2) Develop and share multi-dimensional data organization methods and informatics tools to promulgate innovation, efficiency, quality, and equity in research; 3) Ensure the translational science workforce is diverse and has the skills, knowledge, and resources necessary to advance translation of discoveries within a health equity framework; 4) Support the efficiency, quality, representativeness, and impact of local studies and `raise the bar' for acceptable scientific standards in research conduct; 5) Support the efficiency, quality, representativeness, and impact of multi-site clinical trials by building and disseminating streamlining programs and promoting novel trial designs; and 6) Utilize unique institutional capabilities to enable the conduct of pragmatic trials during healthcare operations and repurpose existing drugs for new indications.

Key facts

NIH application ID
10523600
Project number
2UL1TR002243-06
Recipient
VANDERBILT UNIVERSITY MEDICAL CENTER
Principal Investigator
Gordon Raphael Bernard
Activity code
UL1
Funding institute
NIH
Fiscal year
2022
Award amount
$10,990,565
Award type
2
Project period
2017-06-01 → 2027-02-28